Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

NEXT STORY
Sonoma Pharmaceuticals Announces Asset Purchase Agreement with Middle East Partner MicroSafe Group
PREV STORY
CytomX Therapeutics Announces Full-Year 2019 Financial Results and Provides Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Power Up with Plant Protein

MISSION, Kan., Sept. 01, 2017 (GLOBE NEWSWIRE) -- (Family Features) When it comes to ...

author_avatar
NASDAQ Market News

The Foundation for Women’s Cancer and TESARO Announce 2nd Year of Partnership Supporting the National Race to End Women’s Cancer

CHICAGO and WALTHAM, Mass., Oct. 18, 2017 (GLOBE NEWSWIRE) -- The Foundation for Women’s ...

author_avatar
NASDAQ Market News

BioSig Technologies Issues Shareholder Letter

Minneapolis, MN, July 19, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device ...

author_avatar
NASDAQ Market News